At CLS we are committed to develop safe and effective minimally invasive therapies by providing tools for tissue ablation using heat mediated by laser light. We do this in close collaboration with healthcare professionals to ensure our tools meet their requirements and are seamlessly integrated into existing workflows. This enables more patients to be treated based on their specific diagnosis and needs.
Today, our products are used in minimally invasive focal therapy of patients with localized prostate cancer. As our TRANBERG | Thermal Therapy Systems works with existing imaging, instrument navigation and positioning systems, we allow for a broader use by physicians and more patient treatments. Next, we are expanding into therapy of patients with brain tumors and other lesions through our partnerships.
CLS is also doing research in the field of immune stimulating therapy aiming to trigger the immune response to attack and kill cancer cells throughout the body, the so called abscopal effect. We are convinced that our research in this area will play an important role in the fight against cancer in general.
Welcome to Clinical Laserthermia Systems.
Please note that all our products and indications are not yet approved in all markets. Don’t hesitate to contact us for up-to-date market approvals in your area!
Please choose your country or region
